People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ViroCyt, LLC | — | Other Health Care | Series A | $14.3M | $70.0M | 2012 |
| InDevR, Inc. | — | Biotechnology | Series A | $10.0M | $71.0M | 2019 |
Kathy Rowlen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kathy Rowlen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| MICHAEL CHANG | 1 | 13 |
| Jack Ball | 1 | 10 |
| Robert Kline | 1 | 6 |
| Mark Lupa | 1 | 5 |
| Glenn Rockman | 1 | 3 |
| Walter Young | 1 | 3 |
| Michael Reynier | 1 | 2 |
| Dan Mitchell | 1 | 2 |
| Shannon Rodriguez | 1 | 1 |
| Erica Dawson | 1 | 1 |
| Laura Kuck | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.